Double‐Filtration Plasmapheresis Versus Efgartigimod for Generalized Myasthenia Gravis: Severity‐Stratified Benefits in a Prospective Observational Multicenter Study

20260 citationsJournal Articlegold Open Access

Authors

Kan Wang · Shanghai Jiao Tong University

Hanyu Xin · Punan Hospital

M. Zhang · Shanghai Jiao Tong University

Qiuju Li · Punan Hospital

Yuen Wu · Anhui Provincial Hospital

Xia Li · Anhui Provincial Hospital

Jing Peng · Shanghai Jiao Tong University

Abstract

Both DFPP and EFG effectively treat gMG, though DFPP offers greater benefit in moderate-to-severe cases, underscoring the need for individualized therapy.

Topics & Keywords

Myasthenia Gravis and Thymoma Coagulation, Bradykinin, Polyphosphates, and Angioedema Adrenal Hormones and Disorders

Publication Details

Published in: CNS Neuroscience & Therapeutics

Volume 32, Issue 3, pp. e70838-e70838

DOI: 10.1002/cns.70838

Field-Weighted Citation Impact: 0.00

Command Palette

Double‐Filtration Plasmapheresis Versus Efgartigimod for Generalized Myasthenia Gravis: Severity‐Stratified Benefits in a Prospective Observational Multicenter Study

Authors

Abstract

Topics & Keywords

Publication Details